IAVI and Moderna partner to tackle global health priorities using mRNA for vaccines and antibodies EP News Bureau Apr 8, 2022 Collaboration targets bacterial and viral pathogens including HIV, SARS-CoV-2, antimicrobial-resistant pathogens and tuberculosis
IAVI, Merck KGaA and Serum Institute partner to develop COVID-19 mAbs EP News Bureau Oct 22, 2020 The partnership aims to ensure access to a class of innovative therapies that have, to date, been out of reach in low- and…
